Navigation Links
Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
Date:12/1/2009

dent for Business Development added: "Our research and preclinical development teams have done an excellent job in advancing the program since January of this year. Bayer Schering Pharma's early option exercise is a recognition of Micromet's development capabilities and confirms the promise of our BiTE antibody platform."

About BiTE Antibodies

BiTE® antibodies are designed to direct the body's cytotoxic, or cell-destroying, T cells against tumor cells, and represent a new therapeutic approach to cancer therapy. Typically, antibodies cannot engage T cells because T cells lack the appropriate receptors for binding antibodies. BiTE antibodies have been shown to bind T cells to tumor cells, ultimately inducing a self-destruction process in the tumor cells referred to as apoptosis, or programmed cell death. In the presence of BiTE antibodies, T cells have been demonstrated to serially eliminate tumor cells, which explains the activity of BiTE antibodies at very low concentrations. Through the killing process, T cells start to proliferate, which leads to an increased number of T cells at the site of attack.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® antibody platform, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet's preclinical product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. Micromet's collaboration partners include sanofi-aventis, Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed.

Forward-Looking Statements

This release contains certain forward-looking
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
2. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
5. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
6. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
7. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
8. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
9. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015  When Ryan Rendino ... side of his neck, he figured it ... couple weeks off from weight lifting. ...                               A series of ... referred to Michel Kliot, MD , ...
(Date:5/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that its Board of Directors has ... 2015 of $0.03 per share of common stock outstanding.  ... be paid on June 19, 2015 to all common ... ex-dividend date for the quarterly dividend is June 10, ...
(Date:5/21/2015)... 21. Mai 2015 Dipexium ... ein Unternehmen für Arzneimittel im fortgeschrittenen ... und Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) ... eine wissenschaftliche Posterpräsentation an, welche das ... vorstellt, OneStep-1 und OneStep-2, in der ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... RALEIGH, N.C., Sept. 6, 2011 BioDelivery Sciences ... positive preliminary results from its Phase 1 study ...  BDSI is seeking to develop and commercialize a ... (abuse deterrent agent) for the treatment of opioid ...
... NEW YORK, Sept. 6, 2011 ... new market research report is ... Emerging Pharmaceutical Market ... Between Domestic and International Pharmaceutical ...
Cached Medicine Technology:BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 2BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 3BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 2Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 3Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 5Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 6Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 7Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 8Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 9Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 10Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 11
(Date:5/22/2015)... Carnegie Science Center and Allegheny ... to develop BodyTech, a dynamic, three-pronged health and science ... new exhibit at the Science Center called BodyWorks, the ... traveling science show, Anatomy Adventure, which will hit the ... to explore a wide range of topics surrounding health ...
(Date:5/22/2015)... LINCOLN, R.I. (PRWEB) May 22, 2015 Memorial ... so Amica Insurance is offering some tips to ... National Safety Council, there will be 383 traffic fatalities this ... tips from the National Highway Traffic Safety Association: , ... everyone in the vehicle is wearing a seatbelt, whether they’re ...
(Date:5/22/2015)... TN (PRWEB) May 22, 2015 Power Systems ... Drobeck for the 2015 race season. Drobeck is in his ... serves as a firefighter with the Missoula Fire Department in ... became a Pro in 2014. During his career, he has ... a Pro, Drobeck recorded top 10 finishes in all seven ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 ... Health IT solutions, announced today that Bill Lane, ... is the developer of BlueEHS,a first of its ... offers a customizable Electronic Health Records (EHR) with ... interfaces, a telemedicine-enabled comprehensive patient portal, and more. ...
(Date:5/22/2015)... Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they are ... cosmetic, restorative and other dental treatments. At consultations, ... interest them. Questions regarding what certain treatments can ... also be covered during this initial appointment. If ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2
... 11 CVS/pharmacy, the retail,division of CVS Caremark ... it,is removing oral over-the-counter (OTC) infant cough & ... Consumer Healthcare Products Association,s (CHPA),voluntary withdrawal of these ... is safe and,effective when used as directed. CHPA ...
... 11 SeaView IPA, an Oxnard, CA Network,Services ... Bangasser Memorial,Award for Quality Improvement from the Integrated ... special Awards Ceremony at the 6th,Annual Pay-for-Performance Stakeholders ... The IHA is a statewide leadership group that ...
... have multiple health benefits. Researchers at the University of ... humans from common food-borne diseases. , Researchers Azlin Mustapha, ... Agriculture, Food and Natural Resources, and Atreyee Das, a ... on-going studies examining the inhibitory effects of numerous types ...
... trial data show high acceptance of interactive voice response ... two-thirds of patients prefer automated system, OTTAWA, ON, ... advanced interactive voice response (IVR) solutions, today announced the,general ... use in the healthcare environment. CallAssure uses advanced computer,telephony ...
... Technologies(R),Inc. (OTC Bulletin Board: GLOB), an international ... its Wyndgate,Technologies(R) ("Wyndgate"), division will be a ... Transfusion Medicine Expo (TXPO). (Logo: ... 1947, is a leader in the development ...
... accuracy, and allows hospital pharmacies to accurately manage costs and ... ... VIEW, Calif., Oct. 11 Omnicell, Inc.,(Nasdaq: OMCL ) a ... safety and operational efficiency, today,announced the Omnicell WorkflowRx 5.0 central pharmacy ...
Cached Medicine News:Health News:CVS/pharmacy to Remove OTC Infant Cough & Cold Products from Its Stores as Part of CHPA's Voluntary Withdrawal 2Health News:MED3OOO Client Wins IHA Pay-for-Performance Award 2Health News:MED3OOO Client Wins IHA Pay-for-Performance Award 3Health News:Red wine and grape juice help defend against food-borne diseases, according to MU researchers 2Health News:Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up 2Health News:Vocantas CallAssure provides hospitals with automated solution for post-discharge patient follow-up 3Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 2Health News:Global Med Technologies(R), Inc.'s Division, Wyndgate Technologies(R), to Exhibit at 60th Annual AABB Conference 3Health News:Omnicell Introduces the Next Generation Central Pharmacy Automation Solution 2Health News:Omnicell Introduces the Next Generation Central Pharmacy Automation Solution 3
... 3085 SP Surgical Table combines innovation and ... weighing up to 1,000 lbs. You can ... both normal and reverse orientation and have ... other patients.,The Amsco 3085 SP Table offers ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
... The hands play an important part ... traumatic impairments and rheumatic changes can cause ... developing of the finger-joint prostheses was to ... reproduce the natural function as nearly possible.,The ...
... Profile Leg Holder provides precise control of the ... and maximum exposure of the proximal thigh during ... Holder can be used on both right and ... heights.,The Low Profile Leg Holder can be used ...
Medicine Products: